NKTR·640268306·US·equity·Healthcare - Biotechnology-13D/G
NKTR (NEKTAR THERAPEUTICS) is held by 97 institutional investors as of Q1 2026. Largest holders: FMR LLC ($309.6M), TWO SIGMA INVESTMENTS, LP ($67M), BlackRock, Inc. ($49.8M). Net institutional sentiment: Bullish.
See how NKTR's score breaks down across 4 SEC sources
Showing 1-20 of 107
Data sourced from four SEC data sources: 13F, Form 4, 13D/13G, and STOCK Act. Not financial advice. Full disclaimer